Growing international interest in Hungarian-developed products with reduced deuterium content

HYD Kft.’s products with reduced deuterium content, including Preventa food and dietary supplement products with reduced deuterium content, as well as Vetera-DDW-25, an anti-tumor veterinary medicine, were also presented at the world’s largest pharmaceutical exhibition. More than 2,900 companies presented their innovations at the event taking place in the Milan Fair Center between October 8 and 10, 2024 – for which the organizers expected 62,000 pharmaceutical and commercial professionals from 166 countries around the world. Held annually, the CPhI Exhibition creates a forum for healthcare industry leaders and industry pioneers to form successful collaborations and jointly shape the future of pharmaceuticals. In recent years, the international recognition and recognition of the scientific work and products of HYD Kft. has increased significantly, and at the same time, the demand for products with reduced deuterium content is increasing worldwide. Domestic and international research based on Hungarian scientific discoveries has proven that the naturally occurring heavy hydrogen, deuterium, plays a decisive role in the development of cancer and metabolic diseases. The aim of HYD Kft. is to find new partners, accelerate the development and global expansion of its products, and play a decisive role in the field of health innovations.